Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases (CVDs), a leading global cause of mortality, are characterized by complex ...

Infectious diseases research and clinical practice continue to evolve rapidly, driven by emerging pathogens, antimicrobial resistance, and advances in ...

Detailed price information for Promis Neurosciences Inc (PMN-Q) from The Globe and Mail including charting and trades.

Brain imaging technologies (e.g., MRI, PET, advanced microscopy) are foundational tools for deciphering the brain's ...

The public debate on cannabis is dominated by a tone of normalization—less stigmatization, more freedom of choice. The ...

Scientists have identified a key reason why more than half of people with chronic kidney disease eventually die from heart-related conditions. New evidence shows that damaged kidneys release a ...

In order to explore the medication rules of Shang Han Lun, this article conducted complex network analysis and cluster ...

Cannabis is increasingly normalized, but biology remains unchanged. A review of 64 studies by researchers from Wroclaw ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis ...

Publication includes a systematic review of 24 studies describing off-label cutaneous application of statins in porokeratosis ...

Polaryx believes the addition of Dr. Berger, Mr. Braun, and Dr. Ryan brings valuable expertise across scientific research, clinical development, finance, and corporate strategy, strengthening the ...